Home » Court Affirms Lilly’s Strattera Patent
Court Affirms Lilly’s Strattera Patent
The Federal Circuit on Friday upheld the validity of drugmaker Eli Lilly’s patent for attention deficit hyperactivity disorder drug Strattera, dealing a blow to Actavis Elizabeth, Apotex and other generic-drug makers who had hoped to market a version of the drug.
Law360
Law360
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May